Search Results - "Lechat, P"

Refine Results
  1. 1

    Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: A meta-analysis by DALBY, M, BOUZAMONDO, A, LECHAT, P, MONTALESCOT, G

    Published in Circulation (New York, N.Y.) (14-10-2003)
    “…The benefit of primary percutaneous coronary intervention (PCI) over thrombolysis has been clearly demonstrated in acute myocardial infarction (AMI). However,…”
    Get full text
    Journal Article
  2. 2

    Drug eluting stents: an updated meta-analysis of randomised controlled trials by Roiron, C, Sanchez, P, Bouzamondo, A, Lechat, P, Montalescot, G

    Published in Heart (British Cardiac Society) (01-05-2006)
    “…Objective: To confirm the overall benefit of drug eluting stents (DES), to evaluate the effect of different DES, and to assess the global safety of DES…”
    Get full text
    Journal Article
  3. 3

    Prevention of cardiovascular events in end-stage renal disease: Results of a randomized trial of fosinopril and implications for future studies by Zannad, F., Kessler, M., Lehert, P., Grünfeld, J.P., Thuilliez, C., Leizorovicz, A., Lechat, P., for the Fosidial Investigators

    Published in Kidney international (01-10-2006)
    “…Cardiovascular events (CVEs) are the leading cause of death in chronic hemodialysis patients. Results of trials in non-end-stage renal disease (ESRD) patients…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Deficiency of the 5-hydroxytryptamine transporter gene leads to cardiac fibrosis and valvulopathy in mice by MEKONTSO-DESSAP, A, BROURI, F, ADNOT, S, EDDAHIBI, S, PASCAL, O, LECHAT, P, HANOUN, N, LANFUMEY, L, SEIF, I, BENHAIEM-SIGAUX, N, KIRSCH, M, HAMON, M

    Published in Circulation (New York, N.Y.) (03-01-2006)
    “…Serotonin (5-hydroxytryptamine; 5-HT) overproduction is responsible for cardiac valvular disease in patients with carcinoid tumors. Reduced 5-HT inactivation…”
    Get full text
    Journal Article
  6. 6

    Prevention of atrial fibrillation onset by beta-blocker treatment in heart failure: a meta-analysis by Nasr, Imad Abi, Bouzamondo, Anissa, Hulot, Jean-Sébastien, Dubourg, Olivier, Le Heuzey, Jean-Yves, Lechat, Philippe

    Published in European heart journal (01-02-2007)
    “…Aims Atrial fibrillation (AF) is an important morbidity-mortality risk factor, especially in patients with heart failure (HF). Beta-blockers reduce morbidity…”
    Get full text
    Journal Article
  7. 7

    Impact of ABCC2 polymorphisms on high-dose methotrexate pharmacokinetics in patients with lymphoid malignancy by Simon, N, Marsot, A, Villard, E, Choquet, S, Khe, H-X, Zahr, N, Lechat, P, Leblond, V, Hulot, J-S

    Published in The pharmacogenomics journal (01-12-2013)
    “…Human multidrug resistance-related protein 2 (MRP2, encoded by ABCC2 ) is involved in the transport of anionic drugs such as methotrexate (MTX). We…”
    Get full text
    Journal Article
  8. 8

    Changes in Enoxaparin Pharmacokinetics During Pregnancy and Implications for Antithrombotic Therapeutic Strategy by Lebaudy, C, Hulot, JS, Amoura, Z, Costedoat‐Chalumeau, N, Serreau, R, Ankri, A, Conard, J, Cornet, A, Dommergues, M, Piette, JC, Lechat, P

    Published in Clinical pharmacology and therapeutics (01-09-2008)
    “…Enoxaparin is frequently prescribed for pregnant women who are at high risk for thromboembolic complications. We conducted a population pharmacokinetics study…”
    Get full text
    Journal Article
  9. 9

    Heart conduction disorders related to antimalarials toxicity: an analysis of electrocardiograms in 85 patients treated with hydroxychloroquine for connective tissue diseases by Costedoat-Chalumeau, N., Hulot, J.-S., Amoura, Z., Leroux, G., Lechat, P., Funck-Brentano, C., Piette, J.-C.

    Published in Rheumatology (Oxford, England) (01-05-2007)
    “…Objective. The antimalarial agents chloroquine (CQ) and hydroxychloroquine (HCQ) are used in long-term treatment of connective tissue diseases (CTDs). A high…”
    Get full text
    Journal Article
  10. 10

    Sensitive determination of tenofovir in human plasma samples using reversed-phase liquid chromatography by Sentenac, S., Fernandez, C., Thuillier, A., Lechat, P., Aymard, G.

    “…A new high-performance liquid chromatography assay was developed for the determination of tenofovir, a nucleotide analogue, in plasma. A solid–liquid…”
    Get full text
    Journal Article
  11. 11

    Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the cardiac insufficiency BIsoprolol study (CIBIS) by LECHAT, P, ESCOLANO, S, MALLET, A, GOLMARD, J. L, LARDOUX, H, WITCHITZ, S, HENNEMAN, J. A, MAISCH, B, HETZEL, M, JAILLON, P, BOISSEL, J.-P

    Published in Circulation (New York, N.Y.) (07-10-1997)
    “…To further evaluate the mechanism of beta-blocker-induced benefits in heart failure, the relationships between bisoprolol-induced hemodynamic effects and…”
    Get full text
    Journal Article
  12. 12

    Prognostic value of plasma endothelin-1 in patients with chronic heart failure by Pousset, F., Isnard, R., Lechat, P., Kalotka, H., Carayon, A., Maistre, G., Escolano, S., Thomas, D., Komajda, M.

    Published in European heart journal (01-02-1997)
    “…Aims Endothelin-1 is a potent vasoconstrictive and multifunctional peptide. Elevated concentrations have been reported in congestive heart failure. We…”
    Get full text
    Journal Article
  13. 13

    Plasma adrenomedullin, a new independent predictor of prognosis in patients with chronic heart failure by Pousset, F, Masson, F, Chavirovskaia, O, Isnard, R, Carayon, A, Golmard, J.L, Lechat, P, Thomas, D, Komajda, M

    Published in European heart journal (01-06-2000)
    “…Background Adrenomedullin, a potent endogenous vasodilating and natriuretic peptide, may play an important role in the pathophysiology of chronic heart…”
    Get full text
    Journal Article
  14. 14

    Prevention of heart failure progression : Current approaches by LECHAT, P

    Published in European heart journal (01-02-1998)
    “…Heart failure results from damage and stress to the myocardium whatever the aetiology. An increase in stress by cardiac overload is initially overcome by…”
    Get full text
    Conference Proceeding Journal Article
  15. 15

    Beta-blocker treatment in heart failure. Role of heart rate reduction by Lechat, P

    Published in Basic research in cardiology (01-01-1998)
    “…The potential therapeutic effect of beta-blocker treatment in chronic heart failure is still actively being investigated through large scale clinical trials…”
    Get full text
    Journal Article
  16. 16

    Tracheal Perforation following Double-Lumen Intubation: A case report by ZINGA, E, DANGOISSE, M, LECHAT, J. P

    Published in Acta anaesthesiologica belgica (2010)
    “…Tracheal perforation following endotracheal intubation is an underestimated complication that seriously compromises prognosis. Treatment can be either…”
    Get full text
    Journal Article
  17. 17

    Prognostic benefit of beta-blockers in patients not receiving ACE-Inhibitors by Krum, Henry, Haas, Steven Joseph, Eichhorn, Eric, Ghali, Jalal, Gilbert, Edward, Lechat, Philippe, Packer, Milton, Roecker, Ellen, Verkenne, Patricia, Wedel, Hans, Wikstrand, John

    Published in European heart journal (01-10-2005)
    “…Aims Beta-blockers (BBs) confer significant prognostic benefit in patients (pts) with systolic chronic heart failure (CHF). However, major trials have thus far…”
    Get full text
    Journal Article
  18. 18

    Connection error in the delivery of medical gases to a surgical unit by DANGOISSE, M. J, LALOT, M, LECHAT, J. P

    Published in Acta anaesthesiologica belgica (01-01-2010)
    “…Whilst anesthetic incidents due to problems with the delivery of medical gases to a surgical unit are exceptional, their consequences are potentially drastic…”
    Get full text
    Journal Article
  19. 19

    Does the KCE restrictive policy for preoperative testing lead to increased postoperative complications rate ? by GEORGES, P, KREMER, Y, LEDENT, M, LECHAT, J. P, DE KOCK, M

    Published in Acta anaesthesiologica belgica (01-01-2010)
    “…The majority of the industrialized country tries to contain the health care costs. One of the solutions applied was to restrict preoperative routine testing…”
    Get full text
    Journal Article
  20. 20

    Beta-blocker treatment in heart failure by Bouzamondo, A, Hulot, J S, Sanchez, P, Cucherat, M, Lechat, P

    Published in Fundamental & clinical pharmacology (01-04-2001)
    “…Heart failure treatment has markedly changed during the last few decades, with demonstration of benefit of afterload reduction by vasodilator therapy and…”
    Get full text
    Journal Article